39813 |
Oncology |
Clinical sequencing to assess tumor mutational burden as a useful biom... |
THER ADV MED ONCOL 2021 10.1177/1758835921992992 |
김승태 |
2021 |
39812 |
Medicine, Research & Experimental |
ATM Expression as a Prognostic Marker in Patients With Advanced Biliar... |
IN VIVO 2021 10.21873/invivo.12284 |
김승태 |
2021 |
39811 |
Genetics & Heredity |
Comprehensive molecular characterization of gastric cancer patients fr... |
GENOME MED 2021 10.1186/s13073-021-00826-w |
김승태 |
2021 |
39810 |
Oncology |
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine T... |
CANCER RES TREAT 2021 10.4143/crt.2020.1233 |
김승태 |
2021 |
39809 |
Radiology, Nuclear Medicine & Medical Imaging |
Prediction of epithelial-to-mesenchymal transition molecular subtype u... |
EUR RADIOL 2021 10.1007/s00330-021-08094-3 |
김승태 |
2021 |
39808 |
Oncology |
Impact of Radiotherapy on Kidney Function among Patients Who Received ... |
CANCERS 2021 10.3390/cancers13010059 |
김승태 |
2021 |
39807 |
Multidisciplinary Sciences |
Chromatin accessibility of circulating CD8(+) T cells predicts treatme... |
NAT COMMUN 2021 10.1038/s41467-021-21299-w |
김승태 |
2021 |
39806 |
Oncology |
A randomized phase III trial comparing adjuvant single-agent S1, S-1 w... |
ANN ONCOL 2021 10.1016/j.annonc.2020.11.017 |
김승태 |
2021 |
39805 |
Multidisciplinary Sciences |
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in ... |
NATURE 2021 10.1038/s41586-021-03515-1 |
김승태 |
2021 |
39804 |
Oncology; Pharmacology & Pharmacy |
A phase 1 dose-escalation and dose-expansion study to assess the safet... |
INVEST NEW DRUG 2021 10.1007/s10637-021-01110-9 |
김승태 |
2021 |